International perspectives on AI-driven pharmaceutical IP challenges - Top-Institutions - MDSpire

International perspectives on AI-driven pharmaceutical IP challenges

  • By

  • Grace Y. Wang

  • Jian-Ming Hao

  • Joe G. Chen

  • June 22, 2026

  • 0 min

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    Stanford University
    Stanford University

    Stanford, CA

    Key Differentiators

    • Pharmaceuticals

  • #2

    Mass General Brigham
    Mass General Brigham

    Boston, MA

    Key Differentiators

    • Pharmaceuticals

  • #3

    National Comprehensive Cancer Network (NCCN)
    National Comprehensive Cancer Network (NCCN)

    Fort Washington, PA

    Key Differentiators

    • Pharmaceuticals

Original Source(s)

International perspectives on AI-driven pharmaceutical IP challenges

  • by Grace Y. Wang, Jian-Ming Hao, Joe G. Chen

  • June 22, 2026

Related Content

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

A review of cardiogenic shock studies suggests serial lactate measurements provide more prognostic information than isolated values and may better reflect treatment response.

Coronary Model Shows Limits in Cath-Referred Patients

An interpretable machine-learning model classified angiographic coronary artery disease in patients referred for coronary angiography, but high disease prevalence and unclear inflammatory signals limited clinical interpretation.

Top 10 States Offering Large Physician Loan Repayment Programs

These states offer physician loan repayment and student loan forgiveness programs through state-supported workforce initiatives.